Comorbidities in Children with COVID-19 and MIS-C/PIMS-TS and Risk Factors for Hospitalization, Severe Disease, Intensive Care and Death.
Klin Padiatr
; 234(5): 257-266, 2022 Sep.
Article
in English
| MEDLINE | ID: covidwho-1671685
ABSTRACT
This narrative review sums up data from the SARS-CoV-2-pandemia on preexisting disease/underlying conditions/comorbidities and risk factors in children for severe COVID-19 and MIS-C/PIMS-TS as well as hospitalization and mortality. Young infants and adolescents are at highest risk of hospital and PICU admission. Two or more comorbidities rather than single entities pose a risk for more severe courses of SARS-CoV-2 infection in children. Asthma and malignancy do not increase complication rates. MIS-C/PIMS-TS is not associated with any specific underlying disease.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Prognostic study
/
Reviews
Topics:
Long Covid
Limits:
Adolescent
/
Child
/
Humans
/
Infant
Language:
English
Journal:
Klin Padiatr
Year:
2022
Document Type:
Article
Affiliation country:
A-1727-5895
Similar
MEDLINE
...
LILACS
LIS